Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr;11(2):187-94.
doi: 10.1007/s11910-010-0169-4.

Paraneoplastic neurologic disorders in children

Affiliations

Paraneoplastic neurologic disorders in children

Elizabeth M Wells et al. Curr Neurol Neurosci Rep. 2011 Apr.

Abstract

Paraneoplastic neurologic syndromes are rare disorders that have potentially devastating effects on the developing brain. Recently, there has been increased interest in possible immunotherapy for these disorders. Recognition of paraneoplastic syndromes in children may lead to early detection and treatment of the pediatric cancer and may diminish the neurologic damage that is the major source of morbidity in children with successfully treated tumors. This article reviews the presenting symptoms, immunology, long-term sequelae, and management options for paraneoplastic neurologic syndromes, focusing on those most commonly reported in children: opsoclonus-myoclonus ataxia, limbic encephalitis, and anti-NMDAR encephalitis. The child neurologist plays an important role in recognizing these disorders, initiating a tumor search, and directing ongoing treatment and management of neurologic symptoms after oncologic treatment is complete. Given the rarity of these conditions, multisite collaborative efforts are needed to develop standardized approaches to characterization and treatment.

PubMed Disclaimer

References

    1. Eur J Neurol. 2006 Jul;13(7):682-90 - PubMed
    1. Cytokine. 2008 Oct;44(1):26-32 - PubMed
    1. Lancet Neurol. 2008 Apr;7(4):327-40 - PubMed
    1. Eur J Paediatr Neurol. 2010 Mar;14(2):156-61 - PubMed
    1. Lancet. 2005 Apr 16-22;365(9468):1406-11 - PubMed

MeSH terms

Substances

LinkOut - more resources